These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4831431)

  • 21. [Role of the spleen in immunological processes].
    Robak T; Płuzańska A
    Postepy Hig Med Dosw; 1980; 33(6):625-41. PubMed ID: 6992130
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune surveillance system: its failure and activation.
    Shearer WT; Fink MP
    Prog Hematol; 1977; 10():247-310. PubMed ID: 337362
    [No Abstract]   [Full Text] [Related]  

  • 23. Depressed immunity and the development of cancer.
    Penn I
    Clin Exp Immunol; 1981 Dec; 46(3):459-74. PubMed ID: 7039892
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunostimulation of the lymphodependent phase of neoplastic growth.
    Prehn RT
    J Natl Cancer Inst; 1977 Oct; 59(4):1043-9. PubMed ID: 333119
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunological interrelationships of the body and the tumor].
    Govallo VI
    Vopr Onkol; 1975; 21(10):93-102. PubMed ID: 52944
    [No Abstract]   [Full Text] [Related]  

  • 26. The occurrence of cancer in immune deficiencies.
    Penn I
    Curr Probl Cancer; 1982 Apr; 6(10):1-64. PubMed ID: 7105828
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of immunosuppression in the genesis and growth of malignant tumours.
    Reis HE
    Ger Med Mon; 1971; 1(1):16-21. PubMed ID: 4931500
    [No Abstract]   [Full Text] [Related]  

  • 28. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunologic aspects of cancer.
    Sophocles AM; Nadler SH
    Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunosuppression and cancer: clinical aspects].
    Brouet JC
    Bull Cancer; 1983; 70(1):40-6. PubMed ID: 6839033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-mediated immune response of hamsters to alloantigen and tumor antigens of isologous and autochthonous origin during chemical carcinogenesis.
    Szakal AK; Hanna MG
    Cancer Res; 1974 Jan; 34(1):138-45. PubMed ID: 4588544
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosurveillance and cancer: epidemiologic observations.
    Fraumeni JF; Hoover R
    Natl Cancer Inst Monogr; 1977 Dec; 47():121-6. PubMed ID: 349400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic diagnosis of human cancers.
    Shuster J; Livingstone A; Banjo C; Silver HK; Freedman SO; Gold P
    Am J Clin Pathol; 1974 Aug; 62(2):243-57. PubMed ID: 4135671
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings: Implications of the fetal antigen theory for fetal transplantation.
    Castro JE; Hunt R; Lance EM; Medawar PB
    Cancer Res; 1974 Aug; 34(8):2055-60. PubMed ID: 4842256
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunologic interreactions in neoplastic diseases. A brief review.
    Kushnick T
    Clin Pediatr (Phila); 1971 Jul; 10(7):372-6. PubMed ID: 4933466
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial: The immune system and malignancy: another perspective.
    Bentley HP; Hughes ER; Peterson RD
    J Pediatr; 1975 Sep; 87(3):503-4. PubMed ID: 1100800
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors interfering with immunological rejection of tumours.
    Baldwin RW; Robins RA
    Br Med Bull; 1976 May; 32(2):118-23. PubMed ID: 782631
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunosurveillance and cancer.
    Keast D
    Lancet; 1970 Oct; 2(7675):710-2. PubMed ID: 4195943
    [No Abstract]   [Full Text] [Related]  

  • 39. The suppressor-cell network in cancer (second of two parts).
    Broder S; Waldmann TA
    N Engl J Med; 1978 Dec; 299(24):1335-41. PubMed ID: 362202
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor-specific immune mechanisms.
    Smith RT
    N Engl J Med; 1968 Jun; 278(24):1326-31 concl. PubMed ID: 4869875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.